LawPlayer
My bookmarks
Source

Commission Implementing Regulation (EU) 2019/263 of 14 February 2019 amending Implementing Regulation (EU) No 964/2014 as regards standard terms and conditions for financial instruments for the Co-Investment Facility and for the Urban Development Fund

Commission Implementing Regulation (EU) 2019/263 of 14 February 2019 amending Implementing Regulation (EU) No 964/2014 as regards standard terms and conditions for financial instruments for the Co-Investment Facility and for the Urban Development Fund

Implementing Regulation (EU) 2019/263 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Annexes I, V and VI to Implementing Regulation (EU) No 964/2014 are amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Annexes I, V and VI to Implementing Regulation (EU) No 964/2014 are amended as follows: 1. In Annex I, the annotated table of content of a funding agreement between a managing authority and a financial intermediary is amended as follows: (a) In point 11 a new paragraph is introduced: ‘Provisions on management verifications and audit arrangements in line with paragraphs 1 and 2 of Article 40 of Regulation (EU) No 1303/2013 in cases where the bodies implementing the financial instruments are the EIB or other international financial institutions in which a Member State is a shareholder.’; (b) In point 17, the third paragraph is replaced by the following: ‘Provisions regarding the re-use of resources attributable to the support of the ESI Funds until the end of the eligibility period in compliance with Article 44 of Regulation (EU) No 1303/2013 and, where applicable, provisions regarding differentiated treatment as referred to in Article 43a.’; 2. In Annex V, the terms and conditions for the Co-Investment Facility are amended as follows: (a) in the section ‘Fund Contribution to financial instrument: amount and rate (product details)’, the fourth paragraph is replaced by the following: ‘Differentiated treatment of investors operating under the market economy principle, aimed solely at asymmetric profit-sharing, shall be set in line with Article 43a of Regulation (EU) No 1303/2013 and Article 21(13)(b) of Regulation (EU) No 651/2014.’; (b) in the section ‘Eligible Financial Intermediary and Co-investors’, the third paragraph is replaced by the following: ‘The managing authority and fund of funds shall comply with Union law when selecting financial intermediaries. The selection of financial intermediaries shall be open, transparent, proportionate and non-discriminatory, avoiding conflict of interests. The selection of the financial intermediaries shall establish appropriate risk-sharing arrangements in the case of differentiated treatment and determine possible carried interest.’; 3. In Annex VI, the terms and conditions for the Urban Development Fund are amended as follows: (a) in the section ‘State aid implication’, the fifth paragraph is replaced by the following: ‘Differentiated treatment (asymmetric conditions on risk-sharing arrangements) for the fund of funds, financial intermediary contribution and co-investors contributions at fund level and project level in form of loans, if any, shall be set in accordance with Article 43a of Regulation (EU) No 1303/2013, points (b) and (c) of Article 16(8) of Regulation (EU) No 651/2014, as further specified under the pricing policy.’; (b) in the section ‘Programme contribution to financial instrument: amount and rate (product details)’, the first paragraph is replaced by the following: ‘The actual risk sharing rate, programme public contribution, differentiated treatment and interest rate on loans shall be based on the ex ante assessment findings and shall ensure that the benefit to the final recipients complies with Article 16(8)(b) of Regulation (EU) No 651/2014.’; (c) in the section ‘Lending and risk-sharing at financial intermediary level (alignment of interest)’, the sixth indent is replaced by the following: ‘the risk-sharing with the financial intermediary and with co-investors (at fund level or at urban development project level) shall be made pro-rata as for the programme contribution except if the ex ante assessment as referred in Article 37(2)(c) of Regulation (EU) No 1303/2013 demonstrates that differentiated treatment is needed in the form of an asymmetric risk-sharing set between co-investors. Such arrangements shall be in line with Article 16(8)(b) and (c) of Regulation (EU) No 651/2014 and included in the co-investment agreement between the parties. Such arrangements do not apply to the 1 % invested by the financial intermediary from its own resources as required here above for the purpose of alignment of interest.’; (d) in the section ‘Eligible Financial Intermediaries’, the sixth paragraph is replaced by the following: ‘The managing authority and the fund of funds shall comply with Union law when selecting financial intermediaries. The selection of financial intermediaries shall be open, transparent, proportionate and non-discriminatory, avoiding conflict of interests. The selection of the financial intermediaries shall aim at establishing appropriate risk-sharing arrangements in case of differentiated treatment.’

Other acts of the same type
Commission Implementing Regulation (EU) 2024/1742 of 21 June 2024 extending the derogation from Council Regulation (EC) No 1967/2006 as regards the minimum distance from the coast and depth for shore seines fishing in territorial waters of France adjacent to the coast of Occitanie and the coast of Provence-Alpes-Côte d’AzurCommission Implementing Regulation (EU) 2024/1743 of 21 June 2024 concerning the authorisation of a preparation of endo-1,4-beta-mannanase produced with Thermothelomyces thermophilus DSM 33149 as a feed additive for all poultry species for fattening and ornamental birds (holder of authorisation: BASF SE)Commission Implementing Regulation (EU) 2024/1748 of 21 June 2024 amending Commission Implementing Regulation (EU) 2021/1378 as regards the recognition of certain control bodies in accordance with Article 46 of Regulation (EU) 2018/848 of the European Parliament and of the Council as competent to carry out controls and issue organic certificates in third countries for the purpose of imports of organic products into the UnionCommission Implementing Regulation (EU) 2024/1807 of 21 June 2024 entering a name in the register of traditional specialities guaranteed (Vrbovečka pera (TSG))Commission Regulation (EU) 2024/1719 of 20 June 2024 correcting the Spanish language version of Regulation (EU) No 142/2011 implementing Regulation (EC) No 1069/2009 of the European Parliament and of the Council laying down health rules as regards animal by-products and derived products not intended for human consumption and implementing Council Directive 97/78/EC as regards certain samples and items exempt from veterinary checks at the border under that DirectiveCommission Implementing Regulation (EU) 2024/1720 of 20 June 2024 amending Regulation (EU) 2020/1148 as regards the index compilation of the harmonised indices of consumer pricesCommission Implementing Regulation (EU) 2024/1723 of 20 June 2024 concerning the authorisation of a preparation of Duddingtonia flagrans NCIMB 30336 as a feed additive for grazing animals for milk production of bovine species, sheep and goats (holder of authorisation: International Animal Health Products Pty Ltd, represented by GAB Consulting GmbH)Commission Implementing Regulation (EU) 2024/1727 of 20 June 2024 withdrawing from the market certain feed additivesCommission Implementing Regulation (EU) 2024/1730 of 20 June 2024 concerning the authorisation of benzoic acid as a feed additive for weaned piglets and pigs for fattening (holder of authorisation: LANXESS Chemical B.V.)Commission Implementing Regulation (EU) 2024/1800 of 20 June 2024 entering a name in the register of protected designations of origin and protected geographical indications (Vindelnrökt skinka (PGI))Commission Implementing Regulation (EU) 2024/1802 of 20 June 2024 approving a Union amendment to the product specification for the protected designation of origin Dehesa de ExtremaduraCommission Implementing Regulation (EU) 2024/1696 of 19 June 2024 withdrawing the approval of the active substance acibenzolar-S-methyl in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, amending Commission Implementing Regulation (EU) No 540/2011 and repealing Commission Implementing Regulation (EU) 2016/389

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next